View in EDS

Dosimetry study of 3D-printed noncoplanar template-assisted CT-guided 125I seed implantation for the treatment of recurrent and metastatic tumors in the head and neck.

Saved in:
Bibliographic Details
Title: Dosimetry study of 3D-printed noncoplanar template-assisted CT-guided 125I seed implantation for the treatment of recurrent and metastatic tumors in the head and neck.
Authors: Qiu, Lingyun, Wu, Rong, Chen, Yinan, Xiang, Haixin, Zhan, Wenming, Zhang, Yinghao, Li, Qiang, Liu, Huaxin, Ding, Jieni, Li, Yucheng, Bi, Aihong, Luo, Limin, Jia, Yongshi, Chen, Weijun, Shao, Kainan
Source: PLoS ONE; 8/14/2025, Vol. 20 Issue 8, p1-13, 13p
Subject Terms: HEAD & neck cancer, MEDICAL dosimetry, IODINE, COMPUTED tomography, TUMOR treatment, RADIOTHERAPY, THREE-dimensional printing
Abstract: Objective: Recurrent and metastatic tumors of the head and neck pose significant treatment challenges due to their proximity to critical structures and prior radiation exposure. This study aimed to evaluate the consistency between preoperative and postoperative dosimetric parameters in CT-guided 3D-printed noncoplanar template (3DPNCT)-assisted radioactive iodine-125 seed implantation (RISI). Methods: Twenty-six patients with recurrent or metastatic head and neck cancer were retrospectively analyzed. Gross tumor volume (GTV) coverage and dosimetric parameters such as D90 (dose covering 90% of the GTV), conformity index (CI), and homogeneity index (HI) were compared before and after implantation. The Shapiro-Wilk test was used to assess data normality. Results: There were no significant differences between pre- and postoperative D90, V100, V150, or CI values (P > 0.05). Bland–Altman analysis showed high agreement for key metrics. Conclusions: 3DPNCT-assisted RISI demonstrated accurate dose delivery and high reproducibility. This approach may enhance local control while minimizing radiation to organs at risk in complex head and neck anatomies. These results suggest that this technique has promising clinical applicability in complex head and neck cases; however, further validation through larger prospective studies is warranted to confirm long-term efficacy and safety. [ABSTRACT FROM AUTHOR]
Copyright of PLoS ONE is the property of Public Library of Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Description
Abstract:Objective: Recurrent and metastatic tumors of the head and neck pose significant treatment challenges due to their proximity to critical structures and prior radiation exposure. This study aimed to evaluate the consistency between preoperative and postoperative dosimetric parameters in CT-guided <sup>3</sup>D-printed noncoplanar template (3DPNCT)-assisted radioactive iodine-125 seed implantation (RISI). Methods: Twenty-six patients with recurrent or metastatic head and neck cancer were retrospectively analyzed. Gross tumor volume (GTV) coverage and dosimetric parameters such as D90 (dose covering 90% of the GTV), conformity index (CI), and homogeneity index (HI) were compared before and after implantation. The Shapiro-Wilk test was used to assess data normality. Results: There were no significant differences between pre- and postoperative D90, V100, V150, or CI values (P > 0.05). Bland–Altman analysis showed high agreement for key metrics. Conclusions: 3DPNCT-assisted RISI demonstrated accurate dose delivery and high reproducibility. This approach may enhance local control while minimizing radiation to organs at risk in complex head and neck anatomies. These results suggest that this technique has promising clinical applicability in complex head and neck cases; however, further validation through larger prospective studies is warranted to confirm long-term efficacy and safety. [ABSTRACT FROM AUTHOR]
ISSN:19326203
DOI:10.1371/journal.pone.0330271